|1|Cytokine ILa896 is required in Citrobacter rodentium infectiona89induced intestinal Th17 responses and promotes ILa8922 expression in inflammatory bowel disease. (24430732)
Li L.... Wang H.F.
|2|Increased proportions of bifidobacterium and the lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. (24226927)
Wang W.... Forbes B.A.
|3|Endocrine therapy for growth retardation in paediatric inflammatory bowel disease. (24037779)
Altowati M.A.... Ahmed S.F.
|4|Clostridium difficile infection in children with inflammatory Bowel Disease: Current Evidence. (24180405)
Banaszkiewicz A.... Pituch H.
|5|Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. (24099467)
Moran G.W.... Ghosh S.
|6|Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory care. (24151356)
Weizman A.V.... Nguyen G.C.
|7|AVX-470: a novel oral anti-TNF antibody with therapeutic potential in inflammatory bowel disease. (23949620)
Bhol K.C.... Fox B.S.
|8|Periodontitis and gingivitis in inflammatory bowel disease: a case-control study. (24216685)
Vavricka S.R.... Frei P.
|9|Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic. (23621577)
Podjasek J.O.... Wieland C.N.
|10|Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease. (24183308)
Selhub J.... Crott J.W.
|11|Education and imaging. Gastrointestinal: severe inflammatory bowel disease-associated pyoderma gangrenosum. (24147454)
Freedberg D.E.... Swaminath A.
|12|Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease. (23867874)
Dulai P.S.... Dubinsky M.C.
|13|A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. (24260458)
Tong M.... Braun J.
|14|Inflammatory bowel disease: An archetype disorder of outer environment sensor systems. (23919214)
Actis G.C.... Rosina F.
|15|Help-seeking for fecal incontinence in people with inflammatory bowel disease. (24202227)
Norton C.... Dibley L.
|16|PDCD4/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis. (23224068)
Ludwig K.... Rugge M.
|17|Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. (24237644)
Bryant R.V.... Andrews J.M.
|18|Intestinal and Peripheral Fibrinogen-Like Protein 2 Expression in Inflammatory Bowel Disease. (24287641)
Dong X.... Huang Z.
|19|Management of cytomegalovirus infection in inflammatory bowel diseases. (22538204)
Pillet S.... Roblin X.
|20|Association between inflammatory bowel disease gene 5 (IBD5) and interleukin-23 receptor (IL23R) genetic polymorphisms in Malaysian patients with Crohn's disease. (22908971)
Chua K.H.... Goh K.L.
|21|The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer. (22741617)
Walczak A.... Majsterek I.
|22|Confirmation of three inflammatory bowel disease susceptibility loci in a Chinese cohort. (22426692)
Lv C.... Zhi F.
|23|Hepatosplenic T-cell lymphoma in inflammatory bowel disease: a possible thiopurine-induced chromosomal abnormality. (20927075)
Kotlyar D.S.... Lichtenstein G.R.
|24|Detection of MEFV gene mutations in patients with inflammatory bowel disease. (19309279)
Yurtcu E.... Sahin F.I.
|25|IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations. (17662091)
Haglund S.... Almer S.
|26|Tumour necrosis factor alpha inhibitors: screening for tuberculosis infection in inflammatory bowel disease. (18241178)
Gupta A.... Macrae F.A.
|27|Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study. (19097497)
Shastri Y.M.... Stein J.
|28|Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study. (18928745)
Gisbert J.P.... MatAc J.
|29|ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands. (18047540)
Weersma R.K.... Dijkstra G.
|30|Correlation of the autophagosome gene ATG16L1 polymorphism and inflammatory bowel disease]. (18495612)
Zhi J.... Zhang Y.C.
|31|Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. (17285595)
Kobayashi T.... Hibi T.
|32|Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. (16195422)
Otani T.... Dannenberg A.J.
|33|VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. (16293653)
Goebel S.... Kevil C.G.
|34|Association of Fas-670 gene polymorphism with inflammatory bowel disease in Chinese patients. (15637757)
Xia B.... Li J.
|35|The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. (15842590)
Cantor M.J.... Bernstein C.N.
|36|Intestinal interleukin-13 in pediatric inflammatory bowel disease patients. (15472520)
Kadivar K.... Brown K.A.
|37|Optimizing anti-TNF treatment in inflammatory bowel disease. (15168370)
Rutgeerts P.... Vermeire S.
|38|Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis). (12645796)
PirilAo E.... Maisi P.
|39|Increased expression of interleukin 17 in inflammatory bowel disease. (12477762)
Fujino S.... Fujiyama Y.
|40|Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction. (11995461)
Heikius B.... Lehtola J.
|41|Germ therapy with IL-10 to treat inflammatory bowel diseases. (11074364)
|42|Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. (11196710)
Koss K.... Jewell D.P.
|43|Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. (9771404)
Bhatti M.... Hodgson H.J.
|44|Cytokines in inflammatory bowel disease. (9523521)
Rogler G.... Andus T.
|45|Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. (9658754)
|46|Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases]. (9587492)
Heresbach D.... Semana G.
|47|Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. (8691064)
Grimm M.C.... Doe W.F.
|48|Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. (8129010)
Liu G.T.... Schatz N.J.
|49|Activation of monocytes during inflammatory bowel disease. (1715713)
Andus T.... SchAPlmerich J.
|50|Pneumatosis cystoides intestinalis mimicry of inflammatory bowel disease. (523894)
Liechty E.J.... Strickland R.G.